Alpha Crest Capital Management LLC Neogenomics Inc Transaction History

Alpha Crest Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$7.86 - $12.91 $133,682 - $219,573	17,008 Added 125.02%	30,612 $264,000
Q2 2022 Aug 11, 2022	SELL	$7.06 - $13.97 $20,615 - $40,792	-2,920 Reduced 17.67%	13,604 $111,000
Q1 2022 May 12, 2022	BUY	$12.15 - $35.28 $200,766 - $582,966	16,524 New	16,524 $201,000
Q4 2020 Feb 12, 2021	SELL	$36.08 - $56.47 $696,344 - $1.09 Million	-19,300 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$33.26 - $40.48 $641,918 - $781,263	19,300 New	19,300 $712,000
Q2 2020 Aug 12, 2020	SELL	$24.21 - $31.02 $251,202 - $321,863	-10,376 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$20.5 - $34.53 $410,656 - $691,704	-20,032 Reduced 65.88%	10,376 $286,000
Q4 2019 Feb 12, 2020	BUY	$18.96 - $29.84 $576,535 - $907,374	30,408 New	30,408 $889,000

283

123M

622K

72.2K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.81B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.